BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31265759)

  • 1. Reassessment of hepatitis B virus window periods for two transcription-mediated amplification assays using screening data of South African blood donors.
    Vermeulen M; van Drimmelen H; Coleman C; Sykes W; Reddy R; Busch M; Kleinman S; Lelie N
    Transfusion; 2019 Sep; 59(9):2922-2930. PubMed ID: 31265759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections.
    Vermeulen M; Coleman C; Mitchel J; Reddy R; van Drimmelen H; Ficket T; Lelie N
    Transfusion; 2013 Oct; 53(10 Pt 2):2459-66. PubMed ID: 23621791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay.
    Tsoi WC; Lelie N; Lin CK
    Transfusion; 2013 Oct; 53(10 Pt 2):2477-88. PubMed ID: 23521050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections.
    Vermeulen M; van Drimmelen H; Coleman C; Mitchel J; Reddy R; Lelie N
    Transfusion; 2014 Oct; 54(10):2496-504. PubMed ID: 24749834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing.
    Lelie N; Bruhn R; Busch M; Vermeulen M; Tsoi WC; Kleinman S;
    Transfusion; 2017 Jan; 57(1):24-35. PubMed ID: 27673757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
    Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
    Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct comparison of three residual risk models for hepatitis B virus window period infections using updated input parameters.
    Lelie N; Vermeulen M; van Drimmelen H; Coleman C; Bruhn R; Reddy R; Busch M; Kleinman S
    Vox Sang; 2020 Apr; 115(3):133-145. PubMed ID: 31960480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA; Stramer SL; Kuhns MC; Schlauder GG
    Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.
    Grabarczyk P; van Drimmelen H; Kopacz A; Gdowska J; Liszewski G; Piotrowski D; Górska J; Kuśmierczyk J; Candotti D; Lętowska M; Lelie N; Brojer E
    Transfusion; 2013 Oct; 53(10 Pt 2):2512-24. PubMed ID: 23590145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors.
    Gou H; Pan Y; Ge H; Zheng Y; Wu Y; Zeng J; Yang Z; Pan T; Cun W; Zhou G; Fang G; Zhang J; Zhang K; Zhang R; Sun Y; Xie J; Li J; Wang L
    Transfusion; 2015 Sep; 55(9):2272-81. PubMed ID: 26177670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatitis B virus infection in German blood donors 2008-2015.
    Scheiblauer H; Heiden M; Funk M; Oberle D; Kreß J; Jork C; Chudy M
    Vox Sang; 2020 Apr; 115(3):152-161. PubMed ID: 32023664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity comparison of two Food and Drug Administration-licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield.
    Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Phikulsod S; Oota S; Lin M; Saldanha J; Kleinman SH
    Transfusion; 2011 Sep; 51(9):2012-22. PubMed ID: 21896033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.
    Yang MH; Li L; Hung YS; Hung CS; Allain JP; Lin KS; Tsai SJ
    Transfusion; 2010 Jan; 50(1):65-74. PubMed ID: 19709394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.
    Bouchardeau F; Girault A; Razer A; Servant-Delmas A; Mercier M; Laperche S
    Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
    Kuhns MC; Busch MP
    Mol Diagn Ther; 2006; 10(2):77-91. PubMed ID: 16669606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
    González R; Torres P; Castro E; Barbolla L; Candotti D; Koppelman M; Zaaijer HL; Lelie N; Allain JP; Echevarría JM
    Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.